Abstract

SANTOS, Ibón  and  PEREZ, Andrés. Usefulness of fibroblast growth factor 23 for the prevention of cardiovascular diseases in patients with chronic kidney disease. Rev. Colomb. Cardiol. [online]. 2016, vol.23, n.4, pp.327-332. ISSN 0120-5633.  https://doi.org/10.1016/j.rccar.2015.12.003.

Fibroblast growth factor 23 is a recently discovered protein produced by osteocytes with the primary role of regulating calcium and phosphate homeostasis in the bone and mineral metabolism. Some studies have found evidence suggesting an association between an increase in the concentrations of fibroblast growth factor 23 and an emergence of different cardiovascular pathologies, such as left ventricular hypertrophy, cardiac failure, cardiogenic shock, atherosclerosis, vascular calcification, atrial fibrillation and cerebrovascular accidents. However, further research is required to establish the role of this hormone and the aforementioned conditions.

Keywords : Cardiovascular disease; Metabolism; Calcium; Biomarkers.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )